TITLE

Nonstructural Protein 1 of Influenza A Virus Interacts with Human Guanylate-Binding Protein 1 to Antagonize Antiviral Activity

AUTHOR(S)
Zhu, Zixiang; Shi, Zixue; Yan, Wenjun; Wei, Jianchao; Shao, Donghua; Deng, Xufang; Wang, Shaohui; Li, Beibei; Tong, Guangzhi; Ma, Zhiyong
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Human guanylate-binding protein 1 (hGBP1) is an interferon-inducible protein involved in the host immune response against viral infection. In response to infection by influenza A virus (IAV), hGBP1 transcript and protein were significantly upregulated. Overexpression of hGBP1 inhibited IAV replication in a dose-dependent manner in vitro. The lysine residue at position 51 (K51) of hGBP1 was essential for inhibition of IAV replication. Mutation of K51 resulted in an hGBP1 that was unable to inhibit IAV replication. The viral nonstructural protein 1 (NS1) was found to interact directly with hGBP1. K51 of hGBP1 and a region between residues 123 and 144 in NS1 were demonstrated to be essential for the interaction between NS1 and hGBP1. Binding of NS1 to hGBP1 resulted in a significant reduction in both GTPase activity and the anti-IAV activity of hGBP1. These findings indicated that hGBP1 contributed to the host immune response against IAV replication and that hGBP1-mediated antiviral activity was antagonized by NS1 via binding to hGBP1.
ACCESSION #
87624116

 

Related Articles

  • In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide. Ashton, Laura V.; Callan, Robert L.; Rao, Sangeeta; Landolt, Gabriele A. // Veterinary Medicine International;2010, p1 

    Infection of dogs with canine influenza virus (CIV) is considered widespread throughout the United States following the first isolation of CIV in 2004. While vaccination against influenza A infection is a common and important practice for disease control, antiviral therapy can serve as a...

  • A Novel Ribozyme-Based Prophylaxis Inhibits Influenza A Virus Replication and Protects from Severe Disease. Motard, Julie; Rouxel, Ronan; Paun, Alexandra; von Messling, Veronika; Bisaillon, Martin; Perreault, Jean-Pierre // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Influenza A virus seasonal outbreaks and occasional pandemics represent a global health threat. The high genetic instability of this virus permits rapid escape from the host immune system and emergence of resistance to antivirals. There is thus an urgent need to develop novel approaches for...

  • Heterologous SH3-p85β inhibits influenza A virus replication. Dan-gui Zhang; Wei-zhong Li; Ge-fei Wang; Yun Su; Jun Zeng; Chi Zhang; Xiang-xing Zeng; Xiao-xuan Chen; Yan-xuan Xu; Kang-sheng Li // AIDS Research & Therapy;2010, Vol. 7, p170 

    Phosphatidylinositol 3-kinase (PI3K)/Akt signalling pathway can support the replication of influenza A virus through binding of viral NS1 protein to the Src homology 3 (SH3) domain of p85β regulatory subunit of PI3K. Here we investigated the effect of heterologously overexpressed SH3 on the...

  • Mitophagy in Viral Infections. Xia, Mao; Meng, Gang; Li, Min; Wei, Jiwu // DNA & Cell Biology;Nov2014, Vol. 33 Issue 11, p739 

    Antiviral innate immune responses and apoptosis are the two major factors limiting viral infections. Successful viral infection requires the virus to take advantage of the cellular machinery to bypass cellular defenses. Accumulated evidences show that autophagy plays a crucial role in...

  • Target Cell APOBEC3C Can Induce Limited G-to-A Mutation in HIV-1. Bourara, Khaoula; Liegler, Teri J.; Grant, Robert M. // PLoS Pathogens;Oct2007, Vol. 3 Issue 10, pe153 

    The evolutionary success of primate lentiviruses reflects their high capacity to mutate and adapt to new host species, immune responses within individual hosts, and, in recent years, antiviral drugs. APOBEC3G (A3G) and APOBEC3F (A3F) are host cell DNA-editing enzymes that induce extensive HIV-1...

  • The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Ye, Qiaozhen; Krug, Robert M.; Tao, Yizhi Jane // Nature;12/21/2006, Vol. 444 Issue 7122, p1078 

    Influenza A viruses pose a serious threat to world public health, particularly the currently circulating avian H5N1 viruses. The influenza viral nucleoprotein forms the protein scaffold of the helical genomic ribonucleoprotein complexes, and has a critical role in viral RNA replication. Here we...

  • Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs. Dapat, Clyde; Suzuki, Yasushi; Saito, Reiko; Kyaw, Yadanar; Myint, Yi Yi; Lin, Nay; Oo, Htun Naing; Oo, Khin Yi; Win, Ne; Naito, Makoto; Hasegawa, Go; Dapat, Isolde C.; Zaraket, Hassan; Baranovich, Tatiana; Nishikawa, Makoto; Saito, Takehiko; Suzuki, Hiroshi // Emerging Infectious Diseases;Mar2010, Vol. 16 Issue 3, p493 

    In 2007 and 2008 in Myanmar, we detected influenza viruses A (H3N2) that exhibited reduced sensitivity to both zanamivir and amantadine. These rare and naturally occurring viruses harbored a novel Q136K mutation in neuraminidase and S31N mutation in M2.

  • Interferon-gamma does not restrict influenza virus replication in RAW 264.7 and AMJ2-C11 macrophages through the mechanism involving activation of inducible nitric oxide synthase expression. Kačergius, Tomas; Yuping Deng; Kuhn, Norine S.; Ambrozaitis, Arvydas; Gravenstein, Stefan // Biologija;2007, Issue 3, p51 

    Interferon-gamma (IFN-γ) antiviral activity operates partly via inducible nitric oxide synthase (iNOS) induction. Whether IFN-γ affects influenza A virus (IAV) replication within macrophages through this pathway is unknown. For the investigation, RAW 264.7 and AMJ2-C11 murine macrophages...

  • Inhibition of influenza A virus replication by RNA interference targeted against the PB1 subunit of the RNA polymerase gene. Li, Wanyi; Yang, Xiaofan; Jiang, Yan; Wang, Baoning; Yang, Yuan; Jiang, Zhonghua; Li, Mingyuan // Archives of Virology;Nov2011, Vol. 156 Issue 11, p1979 

    Influenza (flu) pandemics have posed a great threat to human health in the last century. However, current vaccination strategies and antiviral drugs provide limited protection. RNA interference (RNAi) is an effective means of suppressing influenza virus replication. PB1 is the critical protein...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics